Evaluate Cytotoxicity, Leaching, and Structural Conformation of Clear Aligners
Launched by RIYADH ELM UNIVERSITY · Jul 9, 2024
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying clear aligners, which are used to straighten teeth, to see how safe they are and how well they hold up when cleaned with different products. The researchers want to find out if these cleaning tools affect the aligners' structure or release harmful substances. The trial is still in the planning stages and hasn't started recruiting participants yet.
To be eligible for this study, participants must be at least 21 years old, currently using Invisalign clear aligners, and have healthy teeth without cavities. They should also not be pregnant or smoke. If you join the trial, you will help researchers understand more about the safety and effectiveness of clear aligners and their cleaning methods. This is important because it can improve dental care for everyone using these treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants who are on Invisalign Clear aligner treatment.
- • Participants who are 21 years and older and committed to their treatment.
- • Participants with caries-free dentition
- • Participants with no smoking habits
- • Participants are not pregnant females
- Exclusion Criteria:
- • Participants who are on Orthognathic treatment.
- • Participants with Hypodontia.
About Riyadh Elm University
Riyadh Elm University is a leading educational and research institution in Saudi Arabia, dedicated to advancing healthcare through innovative clinical research and evidence-based practice. Committed to fostering academic excellence and community health, the university collaborates with local and international partners to conduct clinical trials that aim to improve patient outcomes and contribute to the global body of medical knowledge. With a focus on ethical standards and regulatory compliance, Riyadh Elm University seeks to drive advancements in medical science while prioritizing the safety and well-being of participants involved in its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Riyadh, , Saudi Arabia
Patients applied
Trial Officials
Omar AlKadhi, BDS,MSc
Principal Investigator
Associated Professor, Riyadh Elm University.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported